Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Antithrombotic effect of Yamanouchi's YM-337

April 3, 1997

E-456, a minimum functional fragment of thrombomodulin from Asahi Chemical

April 3, 1997

New experimental data on Asahi Chemical's ART-123

April 3, 1997

Corvas begins phase Ia trial of rNAPc2

April 3, 1997

Menarini prepares thrombin inhibitors

April 3, 1997

New thrombin inhibitors from Novartis

April 3, 1997

VIMRx licenses factor IXa inhibitor from Columbia University

April 2, 1997

First generic warfarin product cleared by the FDA

April 1, 1997

Genzyme Transgenics receives further funding for development of transgenic ATIII

April 1, 1997

Terumo claims platelet aggregation/thromboxane synthase inhibitors

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...